IRVINE, Calif.--(BUSINESS WIRE)--My Vape Order, Inc. (MVO), a trusted provider of nicotine e-liquid products marketed under the AIR FACTORY® brand, has announced its submission of a bundled Premarket Tobacco Application (PMTA) to the U.S. Food and Drug Administration (FDA) for its suite of 72 AIR FACTORY® products, including both freebase and salt nicotine formulations in a variety of nicotine strengths.
The AIR FACTORY® PMTA submission was electronically filed with FDA on September 3, 2020. Included with the application were robust scientific data including independently-conducted toxicological risk assessments for the submitted products, as well as thorough research findings intended to establish the AIR FACTORY® products as appropriate for the protection of public health. The company’s PMTA filing coincides with the launch of re-designed product packaging for the AIR FACTORY® brand and the implementation of additional safeguards through the company’s B2B and B2C websites to further the company’s commitment to preventing youth exposure to tobacco and nicotine products.
MVO’s CEO, Kyle Godfrey, commented, “Submission of the AIR FACTORY® PMTA marked the culmination of years of planning and hard work for the MVO team and our valued partners. MVO is honored to be a leader in the vape industry, and is proud to provide consumers of tobacco and nicotine products a quality line of e-liquids that consumers can trust and enjoy.” Updates regarding FDA’s PMTA review for the company’s products will be forthcoming.